HU224193B1 - Késleltetett és időzített hatóanyag-felszabadulást biztosító multipartikuláris gyógyszerforma - Google Patents

Késleltetett és időzített hatóanyag-felszabadulást biztosító multipartikuláris gyógyszerforma Download PDF

Info

Publication number
HU224193B1
HU224193B1 HU0102027A HUP0102027A HU224193B1 HU 224193 B1 HU224193 B1 HU 224193B1 HU 0102027 A HU0102027 A HU 0102027A HU P0102027 A HUP0102027 A HU P0102027A HU 224193 B1 HU224193 B1 HU 224193B1
Authority
HU
Hungary
Prior art keywords
water
active ingredient
polymer
coating
pharmaceutical formulation
Prior art date
Application number
HU0102027A
Other languages
English (en)
Hungarian (hu)
Inventor
Edouard Gendrot
Gérard Cousin
Francoise Ragot
Marie-Christine Clee-Bouvet
Original Assignee
Ethypharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm filed Critical Ethypharm
Publication of HUP0102027A2 publication Critical patent/HUP0102027A2/hu
Publication of HUP0102027A3 publication Critical patent/HUP0102027A3/hu
Publication of HU224193B1 publication Critical patent/HU224193B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU0102027A 1998-05-20 1999-05-20 Késleltetett és időzített hatóanyag-felszabadulást biztosító multipartikuláris gyógyszerforma HU224193B1 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9806384A FR2778848B1 (fr) 1998-05-20 1998-05-20 Forme pharmaceutique multiparticulaire a liberation programmee et pulsee et son procede de preparation
PCT/FR1999/001201 WO1999059557A1 (fr) 1998-05-20 1999-05-20 Forme pharmaceutique multiparticulaire a liberation programmee et pulsee et son procede de preparation

Publications (3)

Publication Number Publication Date
HUP0102027A2 HUP0102027A2 (hu) 2002-03-28
HUP0102027A3 HUP0102027A3 (en) 2002-12-28
HU224193B1 true HU224193B1 (hu) 2005-06-28

Family

ID=9526556

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0102027A HU224193B1 (hu) 1998-05-20 1999-05-20 Késleltetett és időzített hatóanyag-felszabadulást biztosító multipartikuláris gyógyszerforma

Country Status (24)

Country Link
EP (1) EP1077687B1 (enExample)
JP (1) JP2002515423A (enExample)
KR (1) KR100583065B1 (enExample)
CN (1) CN1186014C (enExample)
AT (1) ATE214598T1 (enExample)
AU (1) AU758299B2 (enExample)
BG (1) BG64764B1 (enExample)
BR (1) BR9910606A (enExample)
CA (1) CA2333188C (enExample)
DE (1) DE69901062T2 (enExample)
DK (1) DK1077687T3 (enExample)
ES (1) ES2173739T3 (enExample)
FR (1) FR2778848B1 (enExample)
GE (1) GEP20022750B (enExample)
HU (1) HU224193B1 (enExample)
IL (1) IL139774A (enExample)
MX (1) MXPA00011364A (enExample)
NO (1) NO330501B1 (enExample)
NZ (1) NZ508392A (enExample)
PL (1) PL192950B1 (enExample)
PT (1) PT1077687E (enExample)
TR (1) TR200100107T2 (enExample)
WO (1) WO1999059557A1 (enExample)
ZA (1) ZA200006768B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
EP2417969A1 (en) 2004-10-21 2012-02-15 Aptalis Pharmatech, Inc. Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
AU2013273835B2 (en) * 2005-05-02 2016-07-07 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
WO2008136016A1 (en) * 2007-05-08 2008-11-13 Medreich Limited A stable controlled release oral solid dosage form composition and a process thereof
WO2011067667A2 (en) 2009-12-02 2011-06-09 Eurand Pharmaceuticals Limited Fexofenadine microcapsules and compositions containing them
FR2999432B1 (fr) 2012-12-17 2014-12-12 Ethypharm Sa Comprimes orodispersibles obtenus par compression moulage

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2558396B2 (ja) * 1990-06-28 1996-11-27 田辺製薬株式会社 放出制御型製剤
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
FR2754710B1 (fr) * 1996-10-22 1998-12-31 Prographarm Lab Procede de preparation d'une forme pharmaceutique multiparticulaire a liberation controlee plurisequentielle

Also Published As

Publication number Publication date
ATE214598T1 (de) 2002-04-15
BG104963A (en) 2001-07-31
DK1077687T3 (da) 2002-06-17
FR2778848A1 (fr) 1999-11-26
MXPA00011364A (es) 2008-09-09
NO330501B1 (no) 2011-05-02
HUP0102027A2 (hu) 2002-03-28
AU3830299A (en) 1999-12-06
JP2002515423A (ja) 2002-05-28
DE69901062T2 (de) 2002-10-31
GEP20022750B (en) 2002-08-26
TR200100107T2 (tr) 2001-06-21
KR20010052370A (ko) 2001-06-25
IL139774A0 (en) 2002-02-10
BG64764B1 (bg) 2006-03-31
AU758299B2 (en) 2003-03-20
CN1186014C (zh) 2005-01-26
HUP0102027A3 (en) 2002-12-28
NZ508392A (en) 2002-09-27
PL192950B1 (pl) 2006-12-29
PL344314A1 (en) 2001-10-22
FR2778848B1 (fr) 2001-11-23
IL139774A (en) 2005-09-25
KR100583065B1 (ko) 2006-06-08
BR9910606A (pt) 2001-10-02
EP1077687B1 (fr) 2002-03-20
DE69901062D1 (de) 2002-04-25
ZA200006768B (en) 2001-11-20
ES2173739T3 (es) 2002-10-16
CA2333188C (fr) 2010-07-06
NO20005838D0 (no) 2000-11-17
NO20005838L (no) 2001-01-10
CA2333188A1 (fr) 1999-11-25
HK1033271A1 (en) 2001-08-24
WO1999059557A1 (fr) 1999-11-25
CN1305371A (zh) 2001-07-25
PT1077687E (pt) 2002-09-30
EP1077687A1 (fr) 2001-02-28

Similar Documents

Publication Publication Date Title
US6039979A (en) Multiparticulate pharmaceutical form with programmed and pulsed release and process for its preparation
CA2169376C (en) Procedure for encapsulating nsaids
US4784858A (en) Controlled release tablet
CA2473200C (en) Extended release compositions comprising as active compound venlafaxine hydrochloride
ES2606463T3 (es) Combinación de formas de dosificación de levodopa/carbidopa de liberación inmediata y liberación controlada
AU2007267159B2 (en) Lipoic acid pellets
JP2003511351A (ja) 経口投薬形
CA2488868A1 (en) Controlled release formulation of lamotrigine
HU224193B1 (hu) Késleltetett és időzített hatóanyag-felszabadulást biztosító multipartikuláris gyógyszerforma
KR970001656B1 (ko) 조절흡수 딜티아젬 제제
EP0687466A1 (en) Homeopathic formulations
AU2005226927B2 (en) Gastroresistant pharmaceutical dosage form comprising N-(2-(2-phthalimidoethoxy)-acetyl)-L-alanyl-D-glutamic acid (LK-423)
US20060039997A1 (en) Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration
KR20100045528A (ko) 6-머캅토퓨린의 서방형 제제
EP1539113A2 (en) Modified release ketoprofen dosage form
WO2007029081A1 (en) Galantamine-containing controlled release oral dosage forms, processes for the preparation thereof and use for the manufacture of a medicament
JP2528652B2 (ja) 持効性セフラジン製剤
KR20070044911A (ko) 염산 탐스로신 함유 방출조절 제제
MX2014008975A (es) Composicion de nitazoxanida mejorada y proceso para prepararla.
HK1033271B (en) Multiparticulate pharmaceutical form with programmed and timed release and preparation method
KR20020031421A (ko) 경구 투여 형태

Legal Events

Date Code Title Description
HFG4 Patent granted, date of granting

Effective date: 20050420